AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ATOSIBAN

9 registrations across 4 African markets— 9 active

Markets with ATOSIBAN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Tractocile Injection (wrong smpc)
Injection
🇳🇬NigeriaSwan Medico LimitedactiveDec 2028
Tractocile Injection
Injection
🇳🇬NigeriaSwan Medico LimitedactiveDec 2028
TRACTOCILE SOLUTION FOR INJECTION (Each 0.9ml contains Atosiban 6,75mg)🇬🇭GhanaactiveAug 2027
TRACTOCILE SOLUTION FOR INJECTION (Each ml contains Atosiban 7.5mg)🇬🇭GhanaactiveAug 2027
TRACTOCILE SOLUTION FOR INJECTION (Each ml contains Atosiban 7.5mg)🇬🇭GhanaactiveAug 2027
TRACTOCILE SOLUTION FOR INJECTION (Each 0.9ml contains Atosiban 6,75mg)🇬🇭GhanaactiveAug 2027
TRACTOCILE SOLUTION FOR INJECTION🇿🇦South AfricaFerring (Pty) LtdactiveJan 1900
TRACTOCILE CONCENTRATE FOR SOLUTION FOR INFUSION🇿🇦South AfricaFerring (Pty) LtdactiveJan 1900
TRACTOCILE
solution injectable / 6,75 mg
🇸🇳SenegalFERRING PHARMACEUTICALSactive

ATOSIBAN in Africa — Regulatory Overview

ATOSIBAN is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria, South Africa, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.